RSNA 2009

Dec 3, 2009

The German pavilion, one of several international pavilions for RSNA attendees.

none

Snmmi 1 7s Z4 A1v Jrn Thumbnail

SNMMI: New molecular imaging agent shows promise for detecting HCC

June 23, 2025

Women Cancer Patient 400

SNMMI: PET imaging improves OMD detection in breast cancer patients

June 23, 2025

Join Us June 26 at 12 Noon ET for a FREE webinar!

Join Us June 26 at 12 Noon ET for a FREE webinar!

June 12, 2025

Wang Ioy Image Thumbnail

SNMMI: New immuno-PET tracer awarded Image of the Year

June 23, 2025

SNMMI: New molecular imaging agent shows promise for detecting HCC

By Kate Madden Yee

A new molecular imaging agent has shown high sensitivity and specificity in detecting hepatocellular carcinoma (HCC).

June 23, 2025

Snmmi 1 7s Z4 A1v Jrn Thumbnail

SNMMI: PET imaging improves OMD detection in breast cancer patients

By Amerigo Allegretto

PET imaging improves oligometastatic breast cancer detection over conventional imaging.

June 23, 2025

Women Cancer Patient 400

SNMMI: F-18 FDS PET distinguishes molds in invasive fungal infections

Novel PET radiotracer shows promise for molecular imaging infection and inflammation.

June 23, 2025

F18 Fds Pet In Human Snmmi 2025 Johns Hopkins Research Thumbnail

SNMMI: New immuno-PET tracer awarded Image of the Year

A new immuno-PET tracer is superior to conventional F-18 FDG in patients with head and neck cancer.

June 23, 2025

Wang Ioy Image Thumbnail

SNMMI: PET/MRI helps manage patients with chronic spinal pain

F-18 FDG-PET/MRI scans can detect previously unidentified locations of chronic spinal pain.

June 23, 2025

Coronal fused FDG-PET/MRI image of a patient with right upper back pain demonstrates asymetric uptake in the right trapezius muscle without abnormality on MRI to suggest edema or denervation injury. Trigger point lidocaine injection of the area based on PET/MRI findings resulted in complete relief of symptoms (pain score reduced to 0 from a baseline of 6).

SNMMI: Dual-targeting radioligand therapy safe for several cancers

A new "dual-targeting" radioligand therapy has been shown to be safe and effective in humans.

June 22, 2025

Fapi Rgd Thumbnail

Video from SNMMI: Phillip Kuo on new Alzheimer’s disease imaging guidelines

A video interview with Phillip Kuo, MD, PhD, on Alzheimer's disease imaging.

June 22, 2025

Screenshot (2455)

SNMMI: Dual PET/MRI technique could help manage primary aldosteronism

Using two imaging agents with PET/MRI could help manage patients with primary aldosteronism.

June 22, 2025

Pa eymt6 J Xb Ss Thumbnail

SNMMI: Retreatment with Lu-177 PSMA-617 shows promise in mCRPC patients

Retreatment with Lu-177 PSMA-617 is emerging as a potential approach in men with prostate cancer.

June 21, 2025

Gokce Bilgin, MD, presented results of a Pluvicto study June 21 at SNMMI 2025 in New Orleans.

SNMMI: New PET tracers developed for imaging brain disorders

Two newly developed PET imaging agents are effective for identifying a highly expressed receptor in neurological and psychiatric conditions.

June 21, 2025

New H3 Tracers Thumbnail

SNMMI: SPECT/CT valuable after Lu-177 therapy

Post-therapy SPECT/CT imaging can optimize treatment outcomes and protected patients undergoing radiopharmaceutical therapy.

June 21, 2025

Top image displays a patient assessed for acute renal failure following third Lutathera administration where 3D dosimetry showed an average-per-administration kidney absorbed dose of 5 Gray, with total course of therapy being well under toxicity limits. Bottom image displays a patient’s absorbed dose to the colon after his first dose of Pluvicto where 3D dosimetry was used to confirm transient bowel obstruction leading to treatment management.

DL model improves detection of breast arterial calcifications

By Amerigo Allegretto

Researchers have developed a deep-learning (DL) model that can find and characterize breast arterial calcifications on mammograms.

June 20, 2025

2025 06 20 Academicrad Bacs Deep Learning Thumbnail

Page 1 of 147